Abstract: An image forming method to be performed by an image forming apparatus includes forming, transferring, fixing, and drying. The forming forms a foil portion to which foil is adhered on one surface of a recording medium. The transferring transfers an image to the one surface of the recording medium after the forming of the foil portion. The fixing fixes the image transferred to the one surface of the recording medium by the transferring of the image, to form a foil image portion including the foil portion and the image on the recording medium. The drying dries the recording medium on which the foil portion is formed, between the forming of the foil portion and the transferring of the image.

Abstract: Provided is a novel compound or salt thereof that induces degradation by autophagy of an intracellular molecule. In this compound, a ligand having activity to bind to an intracellular molecule and a structure having activity to induce autophagy of an intracellular molecule are linked via a linker without loss of the activity of the ligand and the structure.

Abstract: A displacement output device according to the present invention includes: a memory; and at least one processor coupled to the memory. The processor performing operations. The operations include: acquiring a first ground surface displacement at a first point from a synthetic aperture radar; estimating a second ground surface displacement at a second point different from the first point using the acquired first ground surface displacement; clipping at least one of the first ground surface displacement and the second ground surface displacement included in a preset first region from the first ground surface displacement and the second ground surface displacement; and outputting at least one of the first ground surface displacement and the second ground surface displacement included in the first region.

Abstract: A setting unit sets the operating mode of an aerial vehicle to a first operating mode that transmits, data generated by a host aerial vehicle and data received from another aerial vehicle to a processing device, or a second operating mode that transmits data generated by a host aerial vehicle to another aerial vehicle. At this time, setting unit sets the operating modes of each of a plurality of aerial vehicles using a setting method corresponding to the attributes of an airspace in which aerial vehicle flies, from among a plurality of setting methods that set the operating mode of aerial vehicle. The attributes of an airspace include attributes determined in accordance with a degree of importance pertaining to the process of transmitting data from aerial vehicle to a server device and/or attributes determined in accordance with the extent to which processes are distributed among a plurality of aerial vehicles.

Abstract: Provided include a human IgE antibody that binds to a sweat allergy antigen protein and a human high-affinity IgE receptor but does not induce degranulation in a reaction with the sweat allergy antigen protein, and a composition for treatment or diagnosis of sweat allergy comprising the same.

Abstract: Provided are a sweat allergy antigen, an antibody capable of binding to the antigen specifically, and others, which are produced utilizing a microorganism-originated protein that exists in sweat allergy patient in a dissolved state or a partial peptide of the protein.

Abstract: Provided are a sweat allergy antigen, an antibody capable of binding to the antigen specifically, and others, which are produced utilizing a microorganism-originated protein that exists in sweat allergy patient in a dissolved state or a partial peptide of the protein.

Abstract: Provided are a sweat allergy antigen, an antibody capable of binding to the antigen specifically, and others, which are produced utilizing a microorganism-originated protein that exists in sweat allergy patient in a dissolved state or a partial peptide of the protein.

Abstract: Provided arc a sweat allergy antigen, an antibody capable of binding to the antigen specifically, and others, which are produced utilizing a microorganism-originated protein that exists in sweat allergy patient in a dissolved state or a partial peptide of the protein.

Abstract: Provided include a human IgE antibody that binds to a sweat allergy antigen protein and a human high-affinity IgE receptor but does not induce degranulation in a reaction with the sweat allergy antigen protein, and a composition for treatment or diagnosis of sweat allergy comprising the same.

Abstract: The invention relates to an antibody that inhibits histamine releasing activity induced by an antigenic substance contained in sweat. The invention further relates to an antibody which can react with a sweat antigen composition and inhibit the histamine releasing activity of the composition on a sweat antigen stimulation-responsive cell.

Abstract: An atopic dermatitis inducer binding to a human own IgE antibody and activating mast cells and basophiles, which includes a purified human secretion fraction, or an antigenic molecule or an antigenic determinant in the purified fraction, and obtained through the following steps of: filtering a human secretion, removing insoluble matters and collecting the filtrate; mixing the filtrate with a ConA-affinity carrier and collecting the supernatant; and separating a component having a histamine-releasing activity from the supernatant by column chromatography. This inducer is effective in diagnosing and treating human atopic dermatitis.

Abstract: [Object of the Invention] To provide an antibody that inhibits histamine releasing activity induced by an antigenic substance contained in sweat. [Means for Attaining the Object] An antibody which can react with a sweat antigen composition and inhibit the histamine releasing activity of the composition on a sweat antigen stimulation-responsive cell.

Abstract: An atopic dermatitis inducer binding to a human own IgE antibody and activating mast cells and basophiles, which includes a purified human secretion fraction, or an antigenic molecule or an antigenic determinant in the purified fraction, and obtained through the following steps of: filtering a human secretion, removing insoluble matters and collecting the filtrate; mixing the filtrate with a ConA-affinity carrier and collecting the supernatant; and separating a component having a histamine-releasing activity from the supernatant by column chromatography. This inducer is effective in diagnosing and treating human atopic dermatitis.

Abstract: An atopic dermatitis inducer binding to a human own IgE antibody and activating mast cells and basophiles, which includes a purified human secretion fraction, or an antigenic molecule or an antigenic determinant in the purified fraction, and obtained through the following steps of: filtering a human secretion, removing insoluble matters and collecting the filtrate; mixing the filtrate with a ConA-affinity carrier and collecting the supernatant; and separating a component having a histamine-releasing activity from the supernatant by column chromatography. This inducer is effective in diagnosing and treating human atopic dermatitis.